Side-by-side comparison of AI visibility scores, market position, and capabilities
ArmorCode is an application security posture management platform that unifies security findings across scanning tools into a single risk-prioritized view.
ArmorCode is a cybersecurity company founded in 2020 that provides an Application Security Posture Management (ASPM) platform for enterprises managing complex DevSecOps programs. The platform aggregates vulnerability findings from dozens of security scanning tools including SAST, DAST, SCA, and container scanners, deduplicating and correlating results to provide unified risk visibility across the software development lifecycle. ArmorCode uses AI to prioritize vulnerabilities based on business context, asset criticality, and exploitability, helping security teams focus on risks that matter most. The platform integrates with developer tools including Jira, GitHub, and GitLab to create automated remediation workflows that route findings to the appropriate engineering teams. ArmorCode has raised significant funding and serves large enterprises in financial services, healthcare, and technology that operate mature application security programs with fragmented tooling. The platform addresses the growing challenge of alert fatigue and tool sprawl in enterprise AppSec programs.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.